Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 17 | 2015 | 794 | 2.190 |
Why?
|
| Prostate | 7 | 2014 | 136 | 1.220 |
Why?
|
| S-Phase Kinase-Associated Proteins | 4 | 2015 | 11 | 1.190 |
Why?
|
| Repressor Proteins | 5 | 2015 | 226 | 1.030 |
Why?
|
| Receptors, Androgen | 3 | 2014 | 122 | 0.990 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2014 | 29 | 0.990 |
Why?
|
| PTEN Phosphohydrolase | 13 | 2013 | 53 | 0.960 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2015 | 781 | 0.820 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2013 | 166 | 0.700 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2010 | 200 | 0.630 |
Why?
|
| SOX9 Transcription Factor | 2 | 2014 | 10 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2013 | 245 | 0.610 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2013 | 11 | 0.550 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 6 | 0.530 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 8 | 0.510 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 522 | 0.510 |
Why?
|
| Transcription Factors | 4 | 2014 | 653 | 0.500 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 162 | 0.500 |
Why?
|
| beta Catenin | 1 | 2014 | 46 | 0.490 |
Why?
|
| Cadherins | 1 | 2014 | 82 | 0.480 |
Why?
|
| Mice | 21 | 2015 | 5668 | 0.460 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 287 | 0.450 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 164 | 0.440 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2007 | 184 | 0.420 |
Why?
|
| Ubiquitination | 4 | 2015 | 54 | 0.400 |
Why?
|
| Cell Proliferation | 6 | 2015 | 1149 | 0.400 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2005 | 33 | 0.340 |
Why?
|
| Animals | 23 | 2015 | 14307 | 0.330 |
Why?
|
| Male | 18 | 2015 | 18870 | 0.310 |
Why?
|
| Cell Line, Tumor | 7 | 2014 | 2128 | 0.290 |
Why?
|
| Disease Progression | 5 | 2015 | 580 | 0.290 |
Why?
|
| Cell Nucleus | 3 | 2014 | 351 | 0.270 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 34 | 0.260 |
Why?
|
| Humans | 21 | 2015 | 34853 | 0.230 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 608 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2015 | 897 | 0.220 |
Why?
|
| Down-Regulation | 3 | 2013 | 420 | 0.210 |
Why?
|
| Ubiquitin | 2 | 2013 | 76 | 0.190 |
Why?
|
| Signal Transduction | 6 | 2014 | 1802 | 0.190 |
Why?
|
| Fibroblasts | 4 | 2010 | 252 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1300 | 0.180 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 239 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 3 | 2015 | 247 | 0.170 |
Why?
|
| Neoplasms | 4 | 2015 | 1033 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2010 | 1442 | 0.150 |
Why?
|
| Gene Knockout Techniques | 2 | 2014 | 46 | 0.150 |
Why?
|
| Phosphorylation | 4 | 2013 | 878 | 0.150 |
Why?
|
| Environmental Exposure | 2 | 2015 | 207 | 0.140 |
Why?
|
| Protein Transport | 3 | 2013 | 286 | 0.140 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 211 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 1124 | 0.140 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 1490 | 0.140 |
Why?
|
| Hazardous Substances | 1 | 2015 | 18 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2011 | 21 | 0.130 |
Why?
|
| Models, Genetic | 1 | 2015 | 149 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 65 | 0.130 |
Why?
|
| SUMO-1 Protein | 1 | 2014 | 10 | 0.130 |
Why?
|
| Quinolines | 1 | 2013 | 60 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 58 | 0.110 |
Why?
|
| Imidazoles | 1 | 2013 | 124 | 0.110 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 85 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2010 | 54 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 198 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2012 | 70 | 0.110 |
Why?
|
| Protein Binding | 2 | 2013 | 913 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 161 | 0.110 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 152 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 859 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 95 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 128 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2012 | 54 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 229 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2009 | 834 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2007 | 69 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 39 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 30 | 0.090 |
Why?
|
| Cytosol | 1 | 2009 | 85 | 0.090 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 7 | 0.080 |
Why?
|
| Female | 4 | 2015 | 19873 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2009 | 167 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2008 | 57 | 0.080 |
Why?
|
| Proto-Oncogenes | 1 | 2007 | 19 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 54 | 0.070 |
Why?
|
| Phenotype | 2 | 2009 | 650 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2009 | 287 | 0.070 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2005 | 12 | 0.070 |
Why?
|
| Tuberous Sclerosis | 1 | 2005 | 1 | 0.070 |
Why?
|
| Haplotypes | 1 | 2005 | 152 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 90 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2005 | 322 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2010 | 114 | 0.060 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 2 | 2010 | 6 | 0.050 |
Why?
|
| Hela Cells | 2 | 2012 | 344 | 0.040 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 53 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1530 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 642 | 0.040 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2007 | 9 | 0.040 |
Why?
|
| Proteins | 2 | 2009 | 352 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2011 | 1152 | 0.030 |
Why?
|
| Genotype | 2 | 2009 | 641 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2012 | 8 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 143 | 0.030 |
Why?
|
| Metalloproteases | 1 | 2011 | 16 | 0.030 |
Why?
|
| Chromatin | 1 | 2012 | 164 | 0.030 |
Why?
|
| Histones | 1 | 2012 | 177 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 87 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 44 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2009 | 13 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 123 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 19 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2009 | 18 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 18 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 490 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 87 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 106 | 0.020 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2008 | 13 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 56 | 0.020 |
Why?
|
| Mitosis | 1 | 2009 | 97 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 423 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 341 | 0.020 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2007 | 2 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 249 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2007 | 6 | 0.020 |
Why?
|
| Polyps | 1 | 2007 | 9 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 48 | 0.020 |
Why?
|
| Glutamine | 1 | 2007 | 31 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 605 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 186 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 172 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2011 | 386 | 0.020 |
Why?
|
| Lysine | 1 | 2007 | 104 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 269 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 225 | 0.020 |
Why?
|
| Gene Expression | 1 | 2009 | 639 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 383 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 18 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 9 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 545 | 0.020 |
Why?
|
| Serine | 1 | 2005 | 72 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 269 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2005 | 91 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 181 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2005 | 323 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 162 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 932 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 322 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 1023 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 1289 | 0.010 |
Why?
|